Dan Yrigoyen, Vice President of Sales of Arch Therapeutics, said, “Since the announcement last month that CMS created a HCPCS code for AC5 Advanced Wound System, we have had new product ...

DENVER, March 26, 2025--TriSalus Life Sciences®, Inc. ("TriSalus" or the "Company") (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative ...